Highly porous self-cohered web materials
AssigneeGore Enterprise Holdings, Inc.
InventorsRoy Biran, Edward H. Cully, Ted R. Farnsworth, Charles Flynn, Charles F. White
Life of this patent
Estimating the term…
Abstract
The present invention is directed to implantable bioabsorbable non-woven self-cohered web materials having a very high degree of porosity. The web materials are very supple and soft, while exhibiting proportionally increased mechanical strength in one or more directions. The web materials often possess a high degree of loft. The web materials can be formed into a variety of shapes and forms suitable for use as implantable medical devices or components thereof. In some embodiments, the web materials exhibit significant thrombogenic properties.
Claims18
An implantable thrombogenic article comprising melt-formed abraded filaments and continuous melt-formed filaments to form a porous web material, wherein said material is formed by self-cohering filaments to each other at multiple contact points and then subjecting the material to a carding procedure where at least some of the filaments are engaged and separated from each other, wherein said filaments comprise at least one semi-crystalline polymeric component covalently bonded to or blended with at least one amorphous polymeric component, wherein the filaments possess partial to full polymeric component phase immiscibility when in a crystalline state, wherein said implantable article has a percent porosity greater than ninety absent inclusion of any fillers or other added components that may effectively reduce said porosity, and a relative blood clot time value of approximately 0.7 when compared to the positive citrated calcium control value of 1.0.
An implantable thrombogenic article comprising melt-formed abraded filaments and continuous melt-formed filaments to form a porous web material, wherein said material is formed by self-cohering filaments to each other at multiple contact points and then subjecting the material to a carding procedure where at least some of the filaments are engaged and separated from each other, wherein said filaments comprise a first semi-crystalline polymeric component covalently bonded to or blended with at least one additional semi-crystalline polymeric component, wherein the filaments possess partial to full polymeric component phase immiscibility when in a crystalline state, wherein said implantable article has a percent porosity greater than ninety absent inclusion of any fillers or other added components that may effectively reduce said porosity, and a relative blood clot time value of approximately 0.7 when compared to the positive citrated calcium control value of 1.0.
Dependencies are inferred from the claim text.